ID

22928

Description

Study of XL999 in Patients With Metastatic Renal Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00277316

Lien

https://clinicaltrials.gov/show/NCT00277316

Mots-clés

Versions (1)
  1. 16/06/2017 16/06/2017 -
Téléchargé le

16 juin 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Renal Cell Carcinoma NCT00277316

Anglais

Eligibility Renal Cell Carcinoma NCT00277316

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
males and females with histologically confirmed metastatic clear cell rcc
Description

Clear-cell metastatic renal cell carcinoma

Type de données

boolean

Alias
UMLS CUI [1]
C2931852
measurable disease according to response criteria for solid tumors (recist)
Description

Measurable Disease

Type de données

boolean

Alias
UMLS CUI [1]
C1513041
no prior systemic cytotoxic chemotherapy
Description

Cytotoxic Chemotherapy Systemic

Type de données

boolean

Alias
UMLS CUI [1,1]
C0677881
UMLS CUI [1,2]
C0205373
subjects who have received either no prior therapy for rcc, systemic immunotherapy only (such as interleukin-2 or interferon), or one agent targeting vegf or a vegfr (eg, bevacizumab, sorafenib, or sunitinib malate) may be enrolled
Description

Renal Cell Carcinoma untreated | Immunotherapy Systemic | Interleukin-2 therapy | Interferon therapy | Pharmaceutical Preparation Targeting Vascular Endothelial Growth Factors | Pharmaceutical Preparation Targeting Vascular Endothelial Growth Factor Receptor | bevacizumab | sorafenib | sunitinib malate

Type de données

boolean

Alias
UMLS CUI [1,1]
C0007134
UMLS CUI [1,2]
C0332155
UMLS CUI [2,1]
C0021083
UMLS CUI [2,2]
C0205373
UMLS CUI [3]
C0199975
UMLS CUI [4]
C0279030
UMLS CUI [5,1]
C0013227
UMLS CUI [5,2]
C1521840
UMLS CUI [5,3]
C1256770
UMLS CUI [6,1]
C0013227
UMLS CUI [6,2]
C1521840
UMLS CUI [6,3]
C0148199
UMLS CUI [7]
C0796392
UMLS CUI [8]
C1516119
UMLS CUI [9]
C1700685
ecog performance status of 0 or 1
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy ≥3 months
Description

Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
adequate organ and marrow function
Description

Organ function | Bone Marrow function

Type de données

boolean

Alias
UMLS CUI [1]
C0678852
UMLS CUI [2,1]
C0005953
UMLS CUI [2,2]
C0031843
no other malignancies within 5 years
Description

Malignant Neoplasms Other Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C0332197
signed informed consent
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
radiation to ≥25% of bone marrow within 30 days of xl999 treatment
Description

Therapeutic radiology procedure Bone Marrow Percentage | XL999

Type de données

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0005953
UMLS CUI [1,3]
C0439165
UMLS CUI [2]
C1541529
subjects who have received systemic anticancer therapy within 30 days of xl999 treatment
Description

cancer treatment Systemic | XL999

Type de données

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0205373
UMLS CUI [2]
C1541529
subjects who have not recovered to grade ≤1 or to within 10% of baseline from adverse events due to medications administered >30 days prior to study enrollment
Description

Pharmaceutical Preparations Resulting in Adverse event CTCAE Grades | Recovery Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0332294
UMLS CUI [1,3]
C0877248
UMLS CUI [1,4]
C1516728
UMLS CUI [2,1]
C2004454
UMLS CUI [2,2]
C0332197
history of or known brain metastases, current spinal cord compression or carcinomatous meningitis
Description

Metastatic malignant neoplasm to brain | Compression of spinal cord | Meningeal Carcinomatosis

Type de données

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2]
C0037926
UMLS CUI [3]
C0220654
uncontrolled and/or intercurrent illness
Description

Illness Uncontrolled | Comorbidity

Type de données

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C0009488
pregnant or breastfeeding females
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
known hiv
Description

HIV Infection

Type de données

boolean

Alias
UMLS CUI [1]
C0019693
Retour au début de la page

Similar models

Eligibility Renal Cell Carcinoma NCT00277316

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Clear-cell metastatic renal cell carcinoma
Item
males and females with histologically confirmed metastatic clear cell rcc
boolean
C2931852 (UMLS CUI [1])
Measurable Disease
Item
measurable disease according to response criteria for solid tumors (recist)
boolean
C1513041 (UMLS CUI [1])
Cytotoxic Chemotherapy Systemic
Item
no prior systemic cytotoxic chemotherapy
boolean
C0677881 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
Renal Cell Carcinoma untreated | Immunotherapy Systemic | Interleukin-2 therapy | Interferon therapy | Pharmaceutical Preparation Targeting Vascular Endothelial Growth Factors | Pharmaceutical Preparation Targeting Vascular Endothelial Growth Factor Receptor | bevacizumab | sorafenib | sunitinib malate
Item
subjects who have received either no prior therapy for rcc, systemic immunotherapy only (such as interleukin-2 or interferon), or one agent targeting vegf or a vegfr (eg, bevacizumab, sorafenib, or sunitinib malate) may be enrolled
boolean
C0007134 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0021083 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C0199975 (UMLS CUI [3])
C0279030 (UMLS CUI [4])
C0013227 (UMLS CUI [5,1])
C1521840 (UMLS CUI [5,2])
C1256770 (UMLS CUI [5,3])
C0013227 (UMLS CUI [6,1])
C1521840 (UMLS CUI [6,2])
C0148199 (UMLS CUI [6,3])
C0796392 (UMLS CUI [7])
C1516119 (UMLS CUI [8])
C1700685 (UMLS CUI [9])
ECOG performance status
Item
ecog performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy ≥3 months
boolean
C0023671 (UMLS CUI [1])
Organ function | Bone Marrow function
Item
adequate organ and marrow function
boolean
C0678852 (UMLS CUI [1])
C0005953 (UMLS CUI [2,1])
C0031843 (UMLS CUI [2,2])
Malignant Neoplasms Other Absent
Item
no other malignancies within 5 years
boolean
C0006826 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Informed Consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Therapeutic radiology procedure Bone Marrow Percentage | XL999
Item
radiation to ≥25% of bone marrow within 30 days of xl999 treatment
boolean
C1522449 (UMLS CUI [1,1])
C0005953 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C1541529 (UMLS CUI [2])
cancer treatment Systemic | XL999
Item
subjects who have received systemic anticancer therapy within 30 days of xl999 treatment
boolean
C0920425 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C1541529 (UMLS CUI [2])
Pharmaceutical Preparations Resulting in Adverse event CTCAE Grades | Recovery Absent
Item
subjects who have not recovered to grade ≤1 or to within 10% of baseline from adverse events due to medications administered >30 days prior to study enrollment
boolean
C0013227 (UMLS CUI [1,1])
C0332294 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C1516728 (UMLS CUI [1,4])
C2004454 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Metastatic malignant neoplasm to brain | Compression of spinal cord | Meningeal Carcinomatosis
Item
history of or known brain metastases, current spinal cord compression or carcinomatous meningitis
boolean
C0220650 (UMLS CUI [1])
C0037926 (UMLS CUI [2])
C0220654 (UMLS CUI [3])
Illness Uncontrolled | Comorbidity
Item
uncontrolled and/or intercurrent illness
boolean
C0221423 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0009488 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding females
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
HIV Infection
Item
known hiv
boolean
C0019693 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial